Kohjin Bio Company Description
Kohjin Bio Co., Ltd. manufactures and sells of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
The company offers tissue culture mediums for human cell culture, including human lymphocyte culture, hepatoblastoma-derived cell lines, adipose- derived stem cells, neural stem cells, fibroblast, vascular endothelial cells, and epidermal keratinocyte human cell cultures.
It also provides industrial cell cultures for CHO, hybridomas, and insect cells; exosome production; cryopreservation solutions; cell dissociation agents; adoptCell-NK kits, and bag and other materials.
In addition, the company offers microbial mediums for clinical microbiology culture mediums, microbiology culture medium for food and environment, antimicrobial resistance test kits, and staining kits for microbiology; immunochromatographic assay kit; I-block series; and human blood, serum, and plasma.
Further, it engages in the production and sale of laboratory animal, sale of medical equipment, trust of animal immunization and antibody preparation, and import and export of products and raw materials.
The company was formerly known as Kohjin Co.,Ltd and changed its name to Kohjin Bio Co., Ltd. in 1989.
Kohjin Bio Co., Ltd. was incorporated in 1981 and is headquartered in Sakado, Japan.
| Country | Japan |
| Founded | 1981 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 167 |
| CEO | Takahito Nakamura |
Contact Details
Address: 5-1-3 Sakado, 350-0214 Japan | |
| Phone | 81 49 284 3781 |
| Website | kohjin-bio.jp |
Stock Details
| Ticker Symbol | 177A |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3283630006 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Takahito Nakamura | Chief Executive Officer |